ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,514.00
      1.00%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      68,868.72
      1.41%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Palace Capital Plc (PCA) Quote

      Palace Capital Plc

      Palace Capital Plc (PCA)

      LSE
      234.00
      -2.00
      (-0.85%)
      Closed July 27 11:30AM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      234.00
      Bid
      230.00
      Ask
      236.00
      Volume
      14,320
      234.00 Day's Range 234.00
      200.00 52 Week Range 265.00
      Market Cap
      87.891M
      Previous Close
      236.00
      Open
      234.00
      Last Trade
      5754
      @
      234
      (UT)
      Last Trade Time
      Financial Volume
      33,509p
      VWAP
      234.00
      Average Volume (3m)
      184,708
      Shares Outstanding
      37,560,295
      Dividend Yield
      6.41%
      PE Ratio
      -9.39
      Earnings Per Share (EPS)
      -0.25
      Revenue
      19.6M
      Net Profit
      -9.36M

      About Palace Capital Plc

      Sector
      Real Estate Agents & Mgrs
      Industry
      Real Estate Agents & Mgrs
      Website
      www.palacecapitalplc.com
      Headquarters
      London, Gbr
      Founded
      1970
      Palace Capital Plc is listed in the Real Estate Agents & Mgrs sector of the London Stock Exchange with ticker PCA. The last closing price for Palace Capital was 236p. Over the last year, Palace Capital shares have traded in a share price range of 200.00p to 265.00p.

      Palace Capital currently has 37,560,295 shares outstanding. The market capitalization of Palace Capital is £88.64 million. Palace Capital has a price to earnings ratio (PE ratio) of -9.39.

      PCA Latest News

      More News

      Palace Capital PLC Result of AGM

      Palace Capital PLC 24 July 2024   24 July 2024 Palace Capital plc ("Palace Capital" or the "Company") Results of 2024 Annual General Meeting Palace Capital (LSE: PCA) announces the results of...

      July 24 2024
      RNS Regulatory News

      Palace Capital PLC Holding(s) in Company

      Palace Capital PLC 24 July 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BF5SGF06 Issuer Name PALACE CAPITAL PLC UK or Non-UK Issuer UK 2. Reason...

      July 24 2024
      RNS Regulatory News

      Palace Capital PLC DISPOSALS AND CASH UPDATE

      Palace Capital PLC 24 July 2024   24 July 2024 Palace Capital plc ("Palace Capital" or the "Company") DISPOSALS AND CASH UPDATE Palace Capital (LSE: PCA) announces a disposals and cash update...

      July 24 2024
      RNS Regulatory News

      Palace Capital PLC Holding(s) in Company

      Palace Capital PLC 22 July 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BF5SGF06 Issuer Name PALACE CAPITAL PLC UK or Non-UK Issuer UK 2. Reason...

      July 22 2024
      RNS Regulatory News

      Palace Capital PLC Director/PDMR Shareholding

      Palace Capital PLC 18 July 2024   18 July 2024     Palace Capital PLC ("Palace Capital", the "Company" or the "Group")   PDMR Dealings   Palace Capital (LSE: PCA) announces the following...

      July 18 2024
      RNS Regulatory News

      Palace Capital PLC Holding(s) in Company

      Palace Capital PLC 17 July 2024     TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...

      July 17 2024
      RNS Regulatory News

      Palace Capital PLC Transaction in Own Shares

      Palace Capital PLC 16 July 2024   16 July 2024 Palace Capital plc ("Palace Capital" or the "Company") Transaction in own shares The Company announces that it has purchased the following number...

      July 16 2024
      RNS Regulatory News

      Palace Capital PLC Result of Tender Offer

      Palace Capital PLC 11 July 2024   NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT...

      July 11 2024
      RNS Regulatory News

      Palace Capital PLC Result of General Meeting

      Palace Capital PLC 09 July 2024   9 July 2024 Palace Capital plc ("Palace Capital" or the "Company") Result of General Meeting Palace Capital (LSE: PCA) announces the results of the Company's...

      July 09 2024
      RNS Regulatory News

      Palace Capital PLC Annual Report and Notice of Annual General Meeting

      Palace Capital PLC 19 June 2024   19 June 2024   Palace Capital PLC ("Palace Capital" or the "Company")   Annual Report and Notice of Annual General Meeting Palace Capital (LSE: PCA) announces...

      June 19 2024
      RNS Regulatory News
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      162.6315789473722823722349494230.9311146DE
      4-2-0.847457627119236245219456354234.78481976DE
      12-11-4.48979591837245250219184708234.74014561DE
      262310.9004739336211250200114142232.16463654DE
      52-3-1.26582278481237265200101500238.16958756DE
      156-27-10.344827586226129719593236245.37305314DE
      260-46-16.428571428628034516574625239.61065339DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      WINTWindtree Therapeutics Inc
      $ 8.24
      (150.46%)
      		48.57M
      BFIBurgerFi International Inc
      $ 0.4206
      (97.37%)
      		313.59M
      NBSTWNewbury Street Acquisition Corporation
      $ 0.1349
      (92.71%)
      		122.1k
      YIBOPlanet Image International Ltd
      $ 2.915
      (53.43%)
      		260.07k
      CREVCarbon Revolution Public Ltd
      $ 9.00
      (45.87%)
      		8.06M
      NMHINatures Miracle Holding Inc
      $ 0.2035
      (-48.06%)
      		7.69M
      TANHTantech Holdings Ltd
      $ 0.2585
      (-47.23%)
      		6.75M
      DXCMDexCom Inc
      $ 64.00
      (-40.66%)
      		53.92M
      PSIGPS International Group Ltd
      $ 1.42
      (-31.40%)
      		716.26k
      POAIPredictive Oncology Inc
      $ 1.36
      (-27.27%)
      		6.02M
      SLNASelina Hospitality PLC
      $ 0.0305
      (-18.88%)
      		408.61M
      BFIBurgerFi International Inc
      $ 0.4206
      (97.37%)
      		313.59M
      NVDANVIDIA Corporation
      $ 113.06
      (0.69%)
      		293.33M
      SQQQProShares UltraPro Short QQQ
      $ 9.10
      (-2.88%)
      		176.49M
      SGMOSangamo Therapeutics Inc
      $ 0.8612
      (28.15%)
      		123.71M

      Discussion

      View Full Feed
      MartinLutherKing MartinLutherKing 5 minutes ago
      A bases loaded gran slam brothers
      https://www.think-equity.com/
      RNAZ
      north40000 north40000 6 minutes ago
      There are presentations by AVXL at a Fragile X conference on 7/26 and 7/27, and at AAIC(?), an Alzheimer’s conference, on 7/28 and 7/29. Is that info helpful?
      AVXL
      boston745 boston745 6 minutes ago
      There are three types. Pumpers, bashers, and those who post facts. That said sometimes pumpers/bashers will posts facts but it'll be harder to verify those facts.
      Monksdream Monksdream 6 minutes ago
      BCDA under $3
      https://investorshub.advfn.com/uimage/uploads/2024/7/27/cymckIMG_0041.gif
      BCDA
      FALCON1 FALCON1 6 minutes ago
      https://www.zacks.com/stock/news/2300964/the-zacks-analyst-blog-highlights-danaher-morgan-stanley-pfizer-elite-pharmaceuticals-and-oil-dri

      https://www.zacks.com/stock/news/2300922/zacks-initiates-coverage-of-elite-pharmaceuticals-with-outperform-recommendation
      SCLX
      Tiger Money Tiger Money 6 minutes ago
      Very concerning? One day creates that much consternation for you? I’m sorry to hear that. I often hear how traders/investors trade on emotions rather than due diligence. It still gets me to some degree as well although I have been trading for nearly 35 years. Therefore, I feel bad for you as I
      RDGL
      The_Edge The_Edge 7 minutes ago
      What are the conversion rights of the 300,000 Preferred shares @ $25.00
      which Lion Point received in the settlement
      BFI
      Heisgreater Heisgreater 8 minutes ago
      Excellent post silk and thanks for your continuing informative posts.
      GO KBLB!!!!
      KBLB
      Chartmaster Chartmaster 8 minutes ago
      VOTE TRUMP!!! Deport the illegals! All of them! Make America Great Again!!! Lock up the vandals!
      3331 3331 8 minutes ago
      The Assisi LOOP will automatically turn off after the 15-minute treatment has been delivered. More frequent use could reduce battery life substantially. The battery in this item cannot be recharged or replaced. This product offers 150 15-minute treatments (37.5 hours) for $329.

      Vet Re
      BIEL
      europa7 europa7 8 minutes ago
      Ripple's Game Changing Stablecoin RLUSD & XRP ETF!
      Jul 23, 2024 Thinking Crypto Podcast
      "...Interview with Markus Infanger, SVP of RippleX. We discuss Ripple's upcoming RLUSD stablecoin built on the XRP Ledger and Ethereum..."

      https://www.youtube.com/watch?v=8rwWGUeU5x
      XRPUSD
      WebSlinger WebSlinger 8 minutes ago
      >

      There are over 15 years of PRs, but pumpers claim that the most recent PRs are the only ones that are relevant (since everything else has been shown to be a lie). LOL.

      Even las
      KBLB
      FALCON1 FALCON1 8 minutes ago
      https://www.zacks.com/stock/news/2300964/the-zacks-analyst-blog-highlights-danaher-morgan-stanley-pfizer-elite-pharmaceuticals-and-oil-dri

      https://www.zacks.com/stock/news/2300922/zacks-initiates-coverage-of-elite-pharmaceuticals-with-outperform-recommendation
      LIPO
      Little Pu Little Pu 8 minutes ago
      Arnie1: In Europe we do have the same restrictons...only possible to sell. And I'm already in contact with the Dutch Financial Services Complaints Board on this situation.
      LLBO
      Value_Investor Value_Investor 9 minutes ago
      AFFL will explode to $105.3768 , $18.3515 , and $16.568 respectively based on its two peer's MV at peak and its Record-High MV!

      LOL, even buying its OTC peer (FCCN: Record-High $41.3) at today's high $5.15 = buying AFFL at $13.1402 which is 404.314 Times of current Super-Rid
      AFFL FCCN SSHT
      neomania neomania 9 minutes ago
      JWIZZ where is NSAV Holding COMPANY HQ?
      I know its 2024. They work from home.
      NSAV
      RMS555 RMS555 9 minutes ago
      I live my life and hope/pray for the best..... I pay attention to what is going on but I dont let it affect my day to day routine.

      K*GS is gonna hit next week, so I am in very good mood right now!
      NNRX
      awesomed007 awesomed007 10 minutes ago
      Yes, this stock, company and management team, delivers $% value to shareholders long term. The Chart does not lie %$
      SPZI
      learningcurve2020 learningcurve2020 10 minutes ago
      Your analysis is harmful to retail. I suggest you study the plight of the long suffering TCLN-PPHM-Bavituximab bath water which retail shareholders endured, and the baby turned into symbol CDMO that saved them.
      CDMO
      exwannabe exwannabe 10 minutes ago
      One thing I think many forget is that MHRA can designate a new drug as a “ Promising Innovative Medicine”. DCVAX-L was the first drug out of all of biopharma to be awarded the (PIM) designation.
      And the purpose of the PIM designation? It is a gateway to the EAMS (Early Access Medicine Scheme)
      NWBO
      Monksdream Monksdream 10 minutes ago
      TSHA under $3
      https://investorshub.advfn.com/uimage/uploads/2024/7/27/xgmqxIMG_0040.gif
      TSHA
      BullNBear52 BullNBear52 10 minutes ago
      Prominent Short Seller Accused Of Fraud
      U. S. says Andrew Left manipulated stock prices with misleading reports
      BY DAVE MICHAELS AND JUSTIN BAER

      https://ereader.wsj.net?selDate=20240727&goTo=A001&artid=4&editionStart=The%20Wall Street Journal

      From today's
      FALCON1 FALCON1 11 minutes ago
      https://www.zacks.com/stock/news/2300964/the-zacks-analyst-blog-highlights-danaher-morgan-stanley-pfizer-elite-pharmaceuticals-and-oil-dri

      https://www.zacks.com/stock/news/2300922/zacks-initiates-coverage-of-elite-pharmaceuticals-with-outperform-recommendation
      BFRG
      bobby1151 bobby1151 11 minutes ago
      here is Kelly's e-mail contact info - "kwelan@bielcorp.com"
      BIEL
      vuletini vuletini 11 minutes ago
      Your chart stinks. Smell your fingers....sniff sniff
      XRPUSD

      Your Recent History

      LSE
      PCA
      Palace Capital
      BIT
      F28779
      Vontobel Financial Produ...
      COIN
      BIDSETH
      DeFi Bids
      ASX
      RGIDG
      Roto Gro
      UNSW
      DVIETH
      Dvision
      BIT
      F15672
      Vontobel Financial Produ...
      COIN
      IOPGBP
      Internet of People
      BIT
      F19691
      Vontobel Financial Produ...
      BIT
      GS0217
      Goldman Sachs
      BIT
      F34709
      Vontobel Financial Produ...
      NASDAQ
      AAXEKXX
      Citigroup Global Markets...
      EU
      CSN5D
      CAC SBT 15 NR Decrement 5
      NASDAQ
      ZBGOPX
      Innovation Industries Fu...
      TIDE
      MATICBTC
      Polygon
      EU
      AGIL
      Agility Real Estate
      NASDAQ
      ABFOTXX
      Citigroup Global Markets...
      Delayed Upgrade Clock